Scanning The Human Genome Provide Insights Into The Likelihood Of Future Disease

Scanning The Human Genome Provide Insights Into The Likelihood Of Future Disease.
Stephen Quake, a Stanford University professor of bioengineering, now has a very great intelligence of his own genetic destiny. Quake's DNA was the heart of the first completely mapped genome of a salutary person aimed at predicting future health risks. The read over was conducted by a team of Stanford researchers and cost about $50,000. The researchers say they can now intimate Quake's risk for dozens of diseases and how he might respond to a number of widely used medicines.

This strain of individualized risk report could become common within the next decade and may become much cheaper, according to the Stanford team. "The $1000 genome trial is coming fast. The challenge lies in knowing what to do with all that information. We've focused on establishing priorities that will be most practical when a patient and a physician are sitting together looking at the computer screen," Euan Ashley, an subordinate professor of medicine, said in a university news release.

Those priorities subsume assessing how a person's activity levels, weight, diet and other lifestyle habits ally with his or her genetic risk for, or protection against, health problems such as diabetes or sincerity attack. It's also important to determine if a certain medication is likely to benefit the patient or cause dangerous side effects.

"We're at the dawn of a new age in genomics. Information like this will enable doctors to yield personalized health care like never before. Patients at risk for certain diseases will be able to gain closer monitoring and more frequent testing, while those who are at lower risk will be spared unnecessary tests. This will have signal economic benefits as well, because it improves the efficiency of medicine".